Chronic Lymphoproliferative Disorders: An Integrated Point of View for the Differential Diagnosis

References

• Batata A., Shen B. Diagnostic value of clonality of surface immunoglobulin light and heavy chains in malignant lymphoproliferative disorders. American Journal of Hematology 1993; 43: 263–270
   Web of Science ®Google Scholar
• Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K.C., Clearly M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Muller-Hermelink H. K., Pileri S. A., Piris M. A., Ralfkiaer E., Warnke R. A. A Revised European-American classification of Lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Foon K. A., Todd R. F. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1–31
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M-T., Flandrin G., Galton D. A.G., Gralnick H. R., Sultan C. Proposal for the classification of chronic (mature) B and T lymphoid leukaemias. Journal of Clinical Pathology 1989; 42: 567–584
   PubMed Web of Science ®Google Scholar
• Rothe G., Schmitz G. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Leukemia 1996; 10: 877–895
   PubMed Web of Science ®Google Scholar
• Jennings C. D., Foon K. A. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood 1997; 90: 2863–2892
   PubMed Web of Science ®Google Scholar
• DiGiuseppe J. A., Borowitz M. J. Clinical utility of flow cytometry in the chronic lymphoid leukemias. Seminars in Oncology 1998; 25: 6–10
   PubMed Web of Science ®Google Scholar
• D'Arena G., Del Vecchio L., Carotenuto M. Immunophenotypic characterization of chronic lymphoproliferative disorders. Recent Advances in Hematology, M. Carotenuto. San Giovanni Rotondo, Grafica Baal 1998; 225–244
   Google Scholar
• Frizzera G., Wu C. D., Inghirami G. The usefulness of immunophenotypic and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasms. American Journal of Clinical Pathology 1999; 11(Suppl 1)S13–S19
   Google Scholar
• Gale R. P., Caligaris-Cappio E., Dighiero G., Keating M., Montserrat E., Rai K. Recent progress in chronic lymphocytic leukemia. Leukemia 1994; 8: 1610–1614
   PubMed Web of Science ®Google Scholar
• Rozman C., Montserrat E. Chronic lymphocytic leukemia. The New England Journal of Medicine 1995; 333: 1052–1507
   PubMed Web of Science ®Google Scholar
• O'Brien S., del Giglio A., Keating M. Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood 1995; 85: 307–318
   PubMed Web of Science ®Google Scholar
• Robertson L. E., Plunkett W., McConnell K., Keating M. J., McDonnell T. J. Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome. Leukemia 1996; 10: 456–459
   PubMed Web of Science ®Google Scholar
• Criel A., Verhoef G., Vlietinck R., Mecucci C., Billiet J., Michaux L., Meeus P., Louwagie A., Van Orshoven A., Van Hoof A., Boogaerts M., Van den Berghe H., De Wolf-Peeters C. Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases. British Journal of Haematology 1997; 97: 383–391
   PubMed Web of Science ®Google Scholar
• Cuneo A., Bigoni R., Balboni M., Carli M. G., Piva N., Fagioli F., Latorraca A., Wlodarska I., Van den Berghe H., Castoldi L. Trisomy 12 in chronic lymphocytic leukemia and hairy cell leukemia: a cytogenetic and interphase cytogenetic study. Leukemia and Lymphoma 1994; 15: 167–172
   PubMed Web of Science ®Google Scholar
• Hernandez J. M., Mecucci C., Criel A., Meeus P., Michaux I., Van Hoof A., Verhoef G., Louwagie A., Scheiff J. M., Michaux J. L. Cytogenetic analysis of B cell chronic lymphoid leukemias classified according to morphologic and immunophenotipic (FAB) criteria. Leukemia 1995; 12: 2140–2146
   Google Scholar
• Tefferi A., Bartholmai B. J., Witzig T. E., Jenkins R. B., Li C. Y., Hanson C. A., Mesa R. A., Phyliky R. L. Clinical correlations of immunophenotypic variations and the presence of trisomy 12 in B-cell chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics 1997; 95: 173–177
   PubMed Web of Science ®Google Scholar
• Bigoni R., Cuneo A., Roberti M. G., Bardi A., Rigolin G. M., Piva N., Scapoli G., Spanedda R., Negrini M., Bullrich F., Veronese M. L., Croce C. M., Castoldi G. L. Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study. Leukemia 1997; 11: 1933–1940
   PubMed Web of Science ®Google Scholar
• Tabernero M. D., San Miguel J. L., Garcia J. L., Garcia-Isidoro M., Wiegant J., Ciudad J., Gonzales M., Rios A., Raap A., Orfao A. Clinical, biological, and immunophenotypical characteristics of B-cell chronic lymphocytic leukemia with trisomy 12 by fluorescence in situ hybridization. Cytometry 1995; 22: 217–222
   PubMedGoogle Scholar
• Oscier D. G., Matutes E., Copplestone A., Pickering R. M., Chapman R., Gillingham R., Catovsky D., Hamblin T. J. Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12. British Journal of Haematology 1998 1997; 98: 934–939
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio E., Gobbi M., Bofill M., Janossy G. Unfrequent normal B lymphocytes express features of chronic lymphocytic leukemia. Journal of Experimental Medicine 1985; 155: 623–627
   Web of Science ®Google Scholar
• Caligaris-Cappio F. B-chronic lymphocytic leukemia: a malignancy of anti-self B cells. Blood 1996; 87: 2615–2620
   PubMed Web of Science ®Google Scholar
• Geisler C. H., Larsen J. K., Hansen N. E., Hansen M. M., Christensen B. E., Lund B., Nielsen H., Plesner T., Thorling K., Andersen E., Andersen P. K. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-Cell Chronic Lymphocytic Leukemia. Blood 1991; 78: 1795–1802
   PubMed Web of Science ®Google Scholar
• Almasri N. M., Duque R. E., Iturraspe J., Everett E., Braylan R. C. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. American Journal of Hematology 1992; 40: 259–263
   PubMed Web of Science ®Google Scholar
• Kurek A. S., Threatte G. A., Gottlieb A. J., Smith J. R., Anderson J., Davey F. R. Immunophenotypic sub-classification of chronic lymphocytic leukemia. British Journal of Haematology 1992; 81: 45–51
   PubMed Web of Science ®Google Scholar
• Huh Y., Pugh W. C., Kantarjian H. M., Stass S. A., Cork A., Trujillo J. M., Keating M. J. Detection of subgroups of chronic B-cell leukemias by FMC7 monoclonal antibody. American Journal of Clinical Pathology 1994; 101: 283–289
   PubMed Web of Science ®Google Scholar
• Witzig T. E., Li C-Y., Tefferi A., Katzmann J. A. Measurement of the intensity of cell surface antigen expression in B-cell chronic lymphocytic leukemia. American Journal of Clinical Pathology 1994; 101: 312–317
   PubMed Web of Science ®Google Scholar
• Fournier S., Rubio M., Delespesse G., Sarfati M. Role for low-affinity receptor for IgE (CD23) in normal and leukemic B-cell proliferation. Blood 1994; 84: 1881–1886
   PubMed Web of Science ®Google Scholar
• Tefferi A., Bartholmai B. J., Witzig T. E., Ly C. Y, Hanson C. A., Phyliky R. L. Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemia. American Journal of Clinical Pathology 1996; 106: 457–461
   PubMed Web of Science ®Google Scholar
• Molica S., Dattilo A., Mannella A. CD11c expression in B-cell chronic lymphocytic leukemia. Blood 1993; 81: 2466
   PubMed Web of Science ®Google Scholar
• Matutes E., Owusu-Ankomah K., Morilla R., Garcia Marco J., Houlihan A., Que T. H., Catovsky D. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8: 1640–1645
   PubMed Web of Science ®Google Scholar
• Catovsky D. Chronic lymphoproliferative disorders. Current Opinion in Oncology 1995; 7: 3–11
   PubMedGoogle Scholar
• Catovsky D. Immunophenotypic analysis of chronic lymphoid leukemias. Review of Clinical and Experimental Hematology 1997; 1: 3–14
   Google Scholar
• Pleiman C. M., D'Ambrosio D., Cambier S. C. The B-cell antigen receptor complex: structure and signal transduction. Immunology Today 1994; 15: 393–398
   PubMedGoogle Scholar
• Zomas A. P., Matutes E., Morilla R., Owusu-Ankomah K., Seon B. K., Catovsky D. Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b). Leukemia 1996; 10: 1966–1970
   PubMed Web of Science ®Google Scholar
• Moreau E. J., Matutes E., A'Hern R. P., Morilla R. M., Owusu-Ankomah K. A., Seon B. K., Catovsky D. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). American Journal of Clinical Pathology 1997; 108: 378–382
   PubMed Web of Science ®Google Scholar
• D'Arena G., Cascavilla N., Musto P., Matera R., Carotenuto M. Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders. American Journal of Hematology 1999, (submitted)
   Web of Science ®Google Scholar
• Alfarano A., Indraccolo S., Circosta P., Minuzzo S., Vallario A., Zamarchi R., Fregonese A., Calderazzo F., Faldella A., Aragno M., Camaschella C., Amadori A., Caligaris-Cappio F. An alternative spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia. Blood 1999; 93: 2327–2335
   PubMed Web of Science ®Google Scholar
• Galton D., Goldman J., Wiltshaw E., Catovsky D. Prolymphocyte leukaemia. British Journal of Haematology 1974; 27: 7–23
   PubMed Web of Science ®Google Scholar
• Melo J., Catovsky D., Galton D. The relationship between chronic lymphocytic leukaemia and prolymphocyte leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group. British Journal of Haematology 1985; 63: 377–383
   Web of Science ®Google Scholar
• Giles F J, O'Brien S M, Keating M J. Chronic lymphocytic leukemia in (Richter's) transformation. Semin Oncol 1998; 25: 117–25
   PubMed Web of Science ®Google Scholar
• Frassoldati A., Lampanelli T., Federico M., Annino L., Capnist G., Pagnucco G., Dini E., Resegotti L., Damasio E. E., Silingardi V. Hairy cell leukemia: a clinical review based on 725 cases of the italian cooperative group (1CGHCL). Italian cooperative group for hairy cell leukemia. Leukemia and Lymphoma 1994; 13: 307–316
   PubMed Web of Science ®Google Scholar
• Cheson B. D. Chronic lymphocytic leukemia and hairy-cell leukemia. Current Opinion in Hematology 1994; 1: 268–277
   PubMedGoogle Scholar
• Polliack A. Hairy cell leukemia and allied chronic lymphoid leukemias: current knowledge and new therapeutic options. Leukemia and Lymphoma 1997; 26(Suppl 1)41–51
   PubMed Web of Science ®Google Scholar
• Yam L. T., Li C. Y., Lam K. W. Tartrate resistant acid phosphatase isoenzyme in leukemic reticuloendotheliosis. The New England Journal of Medicine 1971; 284: 357–360
   PubMed Web of Science ®Google Scholar
• Janckila A. J., Cardwell E. M., Yam L. T., Li C-Y. Hairy cell identification by immunochemistry of tartrate-resistant acid phosphatase. Blood 1995; 85: 2839–2844
   PubMed Web of Science ®Google Scholar
• Cawley J. C., Burns G. F., Hayhoe F. J. A chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy cell leukemia. Leukemia Research 1980; 4: 547–559
   PubMed Web of Science ®Google Scholar
• Catovsky D., O'Brien M., Melo J. V., Wardle J., Brozovic M. Hairy cell leukemia (HCL) variant: an intermediate disease between HCL and B prolymphocytic leukemia. Seminars in Oncology 1984; 11: 362–368
   PubMed Web of Science ®Google Scholar
• Lauria F., Raspadori D., Foa R., Zinzani P. L., Buzzi M., Gugliotta L., Macchi S., Tura S. Reduced hematologic response to alpha- interferon therapy in patients with hairy cell leukemia showing a peculiar immunologic phenotype. Cancer 1990; 65: 2233–2236
   PubMed Web of Science ®Google Scholar
• Mulligan S. P., Travade P., Matutes E., Dearden C., Visser L., Poppema S., Catovsky D. B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cells. Blood 1990; 76: 959–964
   PubMed Web of Science ®Google Scholar
• Visser L., Shaw A., Slupsky J., Vos A., Poppema S. Monoclonal antibodies reactive with Hairy Cell Leukemia. Blood 1989; 74: 320–325
   PubMed Web of Science ®Google Scholar
• Robbins B. A., Ellison D. J., Spinosa J. C., Carey C. A., Lukes R. J., Poppema S., Saven A., Piro L. D. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood 1993; 82: 1277–1287
   PubMed Web of Science ®Google Scholar
• Matutes E., Morilla R., Owusu-Ankomah K., Houliham A., Meeus P., Catovsky D. The immunophenotype of Hairy Cell Leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes. Leukemia and Lymphoma 1994; 14: 57–61
   PubMed Web of Science ®Google Scholar
• Melo J. V., Robinson D. S.F., Gregory C., Catovsky D. Splenic lymphoma with “villous” lymphocytes in the peripheral blood: a disorder distinct from hairy cell leukemia. Leukemia 1987; 1: 294–299
   PubMed Web of Science ®Google Scholar
• Melo J. V., Hedge U., Parreira A., Thompson I., Lampert I. A., Catovsky D. Splenic lymphoma with circulating villous lymphocytes: differential diagnosis of B cell leukaemias with large spleens. Journal of Clinical Pathology 1987; 40: 642–651
   PubMed Web of Science ®Google Scholar
• Mulligan S. P., Matutes E., Dearden C., Catovsky D. Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases. British Journal of Haematology 1991; 78: 206–209
   PubMed Web of Science ®Google Scholar
• Imbing F., Jr., Kumar D., Kumar S., Yuoh G., Gardner F. Splenic lymphoma with circulating villous lymphocytes. Journal of Clinical Pathology 1995; 48: 584–587
   PubMed Web of Science ®Google Scholar
• Troussard X., Valensi F., Duchayne E., Garand R., Felman P., Tulliez M., Henry-Amar M., Byron P. A., Flandrin G. Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. British Journal of Haematology 1996; 93: 731–736
   PubMed Web of Science ®Google Scholar
• Brunning R. D., McKenna R. W. Atlas of tumor pathology: tumor of the bone marrow. Armed Forces Institute of Pathology, Washington, DC 1994; 276–291
   Google Scholar
• Sun T., Dittmar K., Koduru P., Susin M., Teichberg S., Brody J. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept. American Journal of Hematology 1996; 51: 282–288
   PubMed Web of Science ®Google Scholar
• Mulligan S. P., Catovsky D. Splenic lymphoma with villous lymphocytes. Leukemia and Lymphoma 1992; 6: 97–105
   Web of Science ®Google Scholar
• Matutes E., Morilla R., Owusu-Ankoman K., Houlihan A., Catovsky D. The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders. Blood 1994; 83: 1558–1562
   PubMed Web of Science ®Google Scholar
• Shivdasani R. A., Hess J. L., Skarin A. T., Pinkus G. S. Intermediate lymphocytic lymphoma: clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma. Journal of Clinical Oncology 1993; 11: 802–811
   PubMed Web of Science ®Google Scholar
• Argatoff L. H., Connors J. M., Klasa R. J., Horsman D. E., Gascoyne R. D. Mantle cell lymphoma: a clinico-pathologic study of 80 cases. Blood 1997; 89: 2067–2078
   PubMed Web of Science ®Google Scholar
• Cohen P. L., Kurtin P. J., Donovan K. A., Hanson P. Immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma. Amererican Journal of Clinical Pathology 1997; 105: 451–457
   Web of Science ®Google Scholar
• Dunphy C. H., Wheaton S. E., Perkins S. L. CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma. Mod Pathology 1997; 10: 818–822
   PubMed Web of Science ®Google Scholar
• Leroux D., Le Marc'hadour R., Gressin R., Jacob M. C., Keddari E., Montreil M., Caillot I., Ialbert P., Sotto J. J. Non-Hodgkin's lymphomas with t(11;14)(q 13;q32): a subset of mantle zone /intermediate lymphocytic lymphoma?. British Journal of Haematology 1991; 77: 346–353
   PubMed Web of Science ®Google Scholar
• Oka K., Ohno T., Kita K., Yamaguchi M., Takakura N., Nishii K., Miwa H., Shirakawa S. PRAD1 gene over-expression in mantle cell lymphoma but nor in other low grade B-cell lymphomas, including extranodal lymphoma. British Journal of Haematology 1994; 86: 786–791
   PubMed Web of Science ®Google Scholar
• Bosch F., Jares P., Campo E. PRAD-1/cyclin Dl gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 1994; 84: 2726–2732
   PubMed Web of Science ®Google Scholar
• Alkan S., Ross C. W., Hanson C. A., Schnitzer B. Follicular lymphoma with involvement of the splenic marginal zone: a pitfall in the differential diagnosis of splenic marginal zone cell lymphoma. Human Pathology 1996; 27: 503–506
   PubMed Web of Science ®Google Scholar
• De Wolf-Peeters C., Pittaluga S., Dierlamm J., Wlodarska I., Van den Berghe H. Marginal zone B-cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma and splenic marginal zone cell lymphoma and their relation to the reactive marginal zone. Leukemia and Lymphoma 1997; 26: 467–478
   PubMed Web of Science ®Google Scholar
• Foon K. A., Gale R. P. Is there a T-cell form of chronic lymphocytic leukemia?. Leukemia 1992; 6: 867–868
   PubMed Web of Science ®Google Scholar
• Matutes E., Catovsky D. CLL should be used only for the disease with B-cell phenotype. Leukemia 1993; 7: 917–918
   PubMed Web of Science ®Google Scholar
• Wong K. F., Chan J. K.C., Sin V. C. T-cell form of the chronic lymphocytic leukaemia: a reaffirmation of its existence. British Journal of Haematology 1996; 93: 157–159
   PubMed Web of Science ®Google Scholar
• Catovsky D., Matutes E., Brito-Bapapulle V. Is T-cell CLL a disease entity?. British Journal of Haematology 1996; 94: 580
   PubMed Web of Science ®Google Scholar
• Hoyer J. D., Ross C. W., Li C-Y., Witzig T. E., Gascoyne R. D., Dewald G. W., Hanson C. A. True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases. Blood 1995; 86: 1163–1169
   PubMed Web of Science ®Google Scholar
• Brunning R. D. T-prolymphocytic leukemia Blood 1991; 78: 3111–3113
   Google Scholar
• Matutes E., Brito-Babapulle V., Swansbury J., Ellis J., Morilla R., Dearden C., Semper A., Catovsky D. Clinical laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 1991; 78: 3269–3274
   PubMed Web of Science ®Google Scholar
• Ginaldi L., Matutes E., Farahat N., De Martinis M., Morilla R., Catovsky D. Differential expression of CD3 and CD7 in T-cell malignancies. A quantitative study by flow cytometry. British Journal of Haematology 1996; 93: 921–927
   PubMed Web of Science ®Google Scholar
• Loughran T. P. Clonal diseases of large granular lymphocytes. Blood 1993; 82: 1–14
   PubMed Web of Science ®Google Scholar
• Semenzato G., Zambello R., Starkebaum G., Oshimi K., Loughran T. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 1997; 89: 256–260
   PubMed Web of Science ®Google Scholar
• Farahat N., Lens D., Zomas A., Morilla R., Matutes E., Catovsky D. Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursors. British Journal of Haematology 1995; 91: 640–646
   PubMed Web of Science ®Google Scholar
• Lavabre-Bertrand T. Flow-cytometric quantitation in chronic leukemias. European Journal of Histochemistry 1996; 40(Suppl 1)33–38
   PubMedGoogle Scholar
• Ginaldi L., De Martinis M., Matutes E., Farahat N., Morilla R., Catovsky D. Levels of expression of CD19 and CD20 in chronic B cell leukaemias. Journal of Clinical Pathology 1998; 51: 364–369
   PubMed Web of Science ®Google Scholar